Certara Services Archives

Fact Sheet

Build investor confidence with science-backed strategy

Discover expert insights on biotech funding, startup investment strategies, and securing capital for biotech ventures.…

CertaraNovember 6, 2025

Press Release

Certara Reports Third Quarter 2025 Financial Results

RADNOR, PA— November 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraNovember 6, 2025

On-Demand Webinar

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Watch the on-demand webinar on avoiding drug launch failure. Learn how smarter development, evidence, and…

CertaraNovember 6, 2025

White Paper

Web of Evidence: A Practical Guide to Managing Document Dependencies in eCTD Submissions

Discover a practical framework to plan, author, and manage regulatory submissions using document dependency mapping.

CertaraNovember 6, 2025

Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

CertaraNovember 5, 2025

On-Demand Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

CertaraNovember 3, 2025

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

CertaraOctober 31, 2025

Blog

At Certara, we’re proud to support WBUR, Boston’s NPR.

Certara supports public radio because NPR is aligned with our values and helps us spread…

CertaraOctober 29, 2025

Blog

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

CertaraOctober 24, 2025

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

CertaraOctober 21, 2025

Certara Services

Build investor confidence with science-backed strategy

Certara Reports Third Quarter 2025 Financial Results

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Web of Evidence: A Practical Guide to Managing Document Dependencies in eCTD Submissions

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

At Certara, we’re proud to support WBUR, Boston’s NPR.

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Newsletter sign up

Quick links

Solutions

Contact